Skin Biopsy Market
Skin Biopsy Market Size, Share &Trends Analysis Report by Type (Shave Biopsy, Punch Biopsy, and Excisional Biopsy), by Indication (Skin Cancer Diagnosis and Staging, Actinic keratosis, Dermatitis, and Others) and by End-User (Hospitals, Diagnostic Laboratories, and Others), Forecast Period (2023-2030)
Skin biopsy market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2023-2030).The market’s growth is attributed to the demand for advanced skincare products. Consumer demand for high-quality skincare products, particularly those designed with prominent and scientifically validated components such as HA, peptides, and antioxidants, continues to rise. The launch of new products stimulates interest and investigation in the skincare sector. For instance, in December 2022, Hydrinity Accelerated Skin Science launched new facial skin care line with well-known ingredients of hyaluronic acid (HA), PPM technology, and numerous peptides and antioxidants. The new skin care line includes a renewing HA serum, a hydrating and healing serum, and a lightweight, microbiome-friendly purifying mist, all designed to reduce signs of aging, improve texture, and accelerate skin healing. However, the high cost of skin biopsy may restrain its growth in low-income economies.
Segmental Outlook
The global skin biopsy market is segmented on the type, indication, and end-user. Based on the type, the market is sub-segmented intoshave biopsy, punch biopsy, and excisional biopsy. Based on the indication, the market is sub-segmented into skin cancer diagnosis and staging, actinic keratosis, dermatitis, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals, diagnostic laboratories, and others. The skin cancer diagnosis and staging subcategory is expected to capture a significant portion of the market share within the indicationsegment. The growth can be attributed to the skin cancer prevalence is increasing, and skin diseases have been diagnosed earlier. In addition, skin cancer needs to be detected and treated as soon as possible to avoid the need for surgery in the case of a dangerous melanoma or other skin cancer.
Diagnostic Laboratories Sub-Segment is Anticipated to Hold a Considerable Share of the global Skin Biopsy Market
Among the end-user, the diagnostic laboratories sub-segment is expected to hold a considerable share in the global Skin Biopsy market. The segmental growth is attributed to the innovative diagnostic approaches. The use of skin biopsy samples to diagnose Alzheimer's disease is an innovative method in neurology. Such innovative approaches broaden the applications of skin biopsies outside dermatology, helping to diversify the skin biopsy industry. For instance,in Feburary 2023, SynapsDx Prepares Launched Skin-Based Alzheimer's Disease Diagnostic Test. Synaps uses three biomarkers to diagnose Alzheimer's disease and differentiate it from other dementia forms. The primary diagnosis is based on morphometric imaging, that measures cell growth in fibroblasts from a patient's skin sample. Alzheimer's patients have fewer large aggregates.
Regional Outlook
The global skin biopsy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increased awareness of skin health, diagnosis, and treatment processes is expected to drive the market throughout the forecast period.
The Global Skin Biopsy Market Growth by Region 2023-2030
The North America Holds Considerin the global Skin Biopsy Market
Regional growth is attributed to themedical need for pediatric skin biopsies.The observations highlight the importance of skin biopsies in the diagnosis of pediatric skin disorders. As a result children and adolescents account for a sizable proportion of biopsy cases, the demand for biopsy equipment and services tailored to younger patients has the potential to drive market expansion.
According to the National Institute of Government, in June 2023, a study analyzed 1308 biopsy records, revealing a male predominance and a majority of patients were adolescents. Furthermore, study found that 12.9% of pediatric skin biopsies were performed, with 83.9% of patients underwent a single biopsy. The majority of patients underwent multiple biopsies, with 98% performing a biopsy for diagnostic purposes. The mean age of patients was 12 years, with males outnumbering females. The study emphasizes the importance of skin biopsies in pediatric patients and the high clinico-histopathologic agreement. Leprosy and papulosquamous diseases were the most common cases.
Market Players Outlook
The major companies serving the skin biopsy market includes Cardinal Health Inc., AccTec Inc., Beckton, Dickenson, and Company, Bio-Rad Laboratories Inc., and Kai Group among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.
For instancein June 2019,Proscia Launched DermAI to Pre-Screen and Classify Skin Biopsies. Proscia's AI-powered software can classify skin disease variants into pre-diagnostic categories, enhancing pathology confidence, quality, and speed, reducing errors and improving laboratory efficiency.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global skin biopsy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Cardinal Health, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Becton, Dickinson, and Co.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Bio-Rad Laboratories, Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
4. Market Segmentation
4.1. Global Skin Biopsy Market by Type
4.1.1. Shave Biopsy
4.1.2. Punch Biopsy
4.1.3. Excisional Biopsy
4.2. Global Skin Biopsy Market by Indication
4.2.1. Skin Cancer Diagnosis and Staging
4.2.2. Actinic Keratosis
4.2.3. Dermatitis
4.2.4. Others (Hair and Nail Disorders, and Autoimmune Skin Disorders)
4.3. Global Skin Biopsy Market by End-User
4.3.1. Hospitals
4.3.2. Diagnostic Laboratories
4.3.3. Others (Research Institutions and Academic Centers, Dermatologists and Pathologists)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AccuTec, Inc.
6.2. Danaher Corp.
6.3. Hologic, Inc.
6.4. Innovia Medical
6.5. Integra LifeSciences
6.6. Jai Surgicals Ltd.
6.7. Kai Corp.
6.8. NIKON CORP.
6.9. Paramount Surgimed Ltd.
6.10. PerkinElmer U.S. LLC
6.11. Roche Diagnostics India Pvt. Ltd.
6.12. Stryker Corp.
6.13. Thermo Fisher Scientific Inc.
6.14. Vernacare
6.15. World Precision Instruments
6.16. Sysmex Corp.
6.17. Bruker Corp.
6.18. Illumina, Inc.
1. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
2. GLOBAL SHAVE SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
3. GLOBAL PUNCH SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
4. GLOBAL EXCISIONAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
5. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL SKIN BIOPSY IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
14. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
15. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
16. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
17. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
18. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
19. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
20. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
21. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
22. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
23. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
24. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
25. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
26. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
27. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
28. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
29. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
30. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
1. GLOBAL SKIN BIOPSY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
2. GLOBAL SHAVE SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
3. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
5. GLOBAL SKIN BIOPSY MARKET SHARE BY INDICATION, 2022 VS 2030 (%)
6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL SKIN BIOPSY IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
10. GLOBAL SKIN BIOPSY MARKET SHARE BY END-USER, 2022 VS 2030 (%)
11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
14. GLOBAL SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
15. US SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
16. CANADA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
17. UK SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
18. FRANCE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
19. GERMANY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
20. ITALY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
21. SPAIN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
22. REST OF EUROPE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
23. INDIA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
24. CHINA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
25. JAPAN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
26. SOUTH KOREA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
27. REST OF ASIA-PACIFIC SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
28. REST OF THE WORLD SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
